KR950704252A - N-치환 이미다졸 유도체 - Google Patents
N-치환 이미다졸 유도체Info
- Publication number
- KR950704252A KR950704252A KR1019950702463A KR19950702463A KR950704252A KR 950704252 A KR950704252 A KR 950704252A KR 1019950702463 A KR1019950702463 A KR 1019950702463A KR 19950702463 A KR19950702463 A KR 19950702463A KR 950704252 A KR950704252 A KR 950704252A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- substituted
- halogen atom
- carbon atoms
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
목적 :
α1―아드레날린 수용체를 차단함으로서 강압작용 및 배뇨장해 개선 작용을 갖는 화합무을 제공하는 것.
구성 :
하기 식
(식중, R1은 알킬기, 페닐기 또는 할로겐원자, 알킬기 또는 알콕시기로 치환된 페닐기를 나타내며; R2는 페닐기, 할로겐 원자, 알킬기, 알콕시기 및 피페리디노기로부터 선택된 기 중 1개 또는 2개로 치환된 페닐기, 2―피리딜기 또는 할로겐원자, 알킬기 및 알콕시기로부터 선택된 기 중 1개 또는 2개로 치환된 2―피리딜기를 나타내고, n은 2∼5의 정수를 나타낸다)로 표시되는 N―치환 인돌 유도체 및 산부가염.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (1)
- 하기 식(식중, R1은 탄소원자수 1∼8개의 알킬기, 페닐기 또는 「할로겐 원자, 탄소원자수 1∼4개의 알킬기 또는 탄소원자수 1∼4개의 알콕시기」로 치환된 페닐기를 나타내며; R2는 페닐기, 「할로겐 원자, 탄소원자수 1∼4개의 알킬기, 탄소원자수 1∼4개의 알콕시기 및 피페리디노기」로부터 선택된 기 중 1개 또는 2개로 치환된 페닐기, 2―피리딜기 또는 「할로겐원자, 탄소원자수 1∼4개의 알킬기 및 탄소원자수 1∼4개의 알콕시기」로부터 선택된 기 중1개 또는 2개로 치환된 2―피리딜기를 나타내고; n은 2∼5의 정수를 나타낸다)로 표시되는 N―치환 인돌유도체 및 산부가염.※ 참고사항:최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34044892 | 1992-12-21 | ||
JP340448/1992 | 1992-12-21 | ||
JP4492793 | 1993-03-05 | ||
JP44927/1993 | 1993-03-05 | ||
PCT/JP1993/001845 WO1994014769A1 (en) | 1992-12-21 | 1993-12-21 | N-substituted indole derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
KR950704252A true KR950704252A (ko) | 1995-11-17 |
Family
ID=26384893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950702463A KR950704252A (ko) | 1992-12-21 | 1993-12-21 | N-치환 이미다졸 유도체 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0675109A1 (ko) |
KR (1) | KR950704252A (ko) |
AU (1) | AU5715494A (ko) |
CA (1) | CA2152160A1 (ko) |
WO (1) | WO1994014769A1 (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5760040A (en) * | 1994-03-30 | 1998-06-02 | Zeria Pharmaceutical Co., Ltd. | Indole derivative for treating overproduction of dihydrotestosterone |
WO1999057131A1 (en) | 1998-05-06 | 1999-11-11 | Duke University | Method of treating bladder and lower urinary tract syndromes |
US6133453A (en) * | 1998-05-15 | 2000-10-17 | Pharm-Eco Laboratories, Inc. | Method for making substituted indoles |
FR2793793B1 (fr) * | 1999-05-19 | 2004-02-27 | Adir | Nouveaux derives dimeriques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2827287B1 (fr) * | 2001-07-13 | 2003-10-31 | Servier Lab | Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO2015090235A1 (en) | 2013-12-20 | 2015-06-25 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62258369A (ja) * | 1986-05-02 | 1987-11-10 | Nippon Soda Co Ltd | キナゾリノン誘導体及びその製造方法 |
US4980365A (en) * | 1987-07-13 | 1990-12-25 | Hoechst-Roussel Pharmaceuticals Inc. | N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents |
US4954502A (en) * | 1988-06-10 | 1990-09-04 | Bristol-Myers Squibb Company | 1-indolyalkyl-4-(substituted-pyridinyl)piperazines |
GB8830312D0 (en) * | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
-
1993
- 1993-12-21 AU AU57154/94A patent/AU5715494A/en not_active Abandoned
- 1993-12-21 CA CA002152160A patent/CA2152160A1/en not_active Abandoned
- 1993-12-21 KR KR1019950702463A patent/KR950704252A/ko not_active Application Discontinuation
- 1993-12-21 WO PCT/JP1993/001845 patent/WO1994014769A1/ja not_active Application Discontinuation
- 1993-12-21 EP EP94903029A patent/EP0675109A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU5715494A (en) | 1994-07-19 |
WO1994014769A1 (en) | 1994-07-07 |
CA2152160A1 (en) | 1994-07-07 |
EP0675109A1 (en) | 1995-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960704919A (ko) | 신규인 펩티드 유도체 (novel peptide derivative) | |
KR910016742A (ko) | 알킬화된 옥소-피페라진일-트리아진 | |
KR930702254A (ko) | 아닐리드 유도체 | |
KR890005084A (ko) | 퀴놀린 유도체 | |
ATE25682T1 (de) | Indol-3-carboxamid-derivate. | |
KR930700106A (ko) | 혈전증 치료제 및 포스포 디에스테라제 저해제 | |
DK0514277T3 (da) | 3-aminopyradazinderivater med virkning på centralnervesystemet | |
KR960007592A (ko) | 신규한 피롤로카바졸 | |
KR900006296A (ko) | 이미다졸린 유도체 및 그의 제조방법 | |
KR910019977A (ko) | 카르바졸 화합물 | |
KR900004820A (ko) | 안정화된 합성수지조성물 | |
DK657988D0 (da) | Substituerede alkylaminderivater, deres fremstilling og anvendelse | |
KR950704252A (ko) | N-치환 이미다졸 유도체 | |
DK671688A (da) | 2-(piperazinyl)-2-oxoethylensubstituerede flavonoidderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse | |
KR920016448A (ko) | 피페리딘 유도체 | |
KR920701120A (ko) | 치환된 비시클로헵탄디온 유도체 | |
DK0806413T3 (da) | 2-substituerede viatmin D3-derivater | |
KR960700245A (ko) | 메토트렉세이트 유도체[methotrexate derivative] | |
KR900006316A (ko) | 벤조 헤테로 고리화합물 및 그 제조방법 | |
DK0594329T3 (da) | Antimikrobielle midler, der omfatter polykvaternære ammoniumforbindelser | |
KR890016006A (ko) | 피롤 유도체 | |
KR930702339A (ko) | 에폭시숙시남산 유도체 | |
KR880005076A (ko) | 2-아제티디논 유도체 | |
KR930023031A (ko) | 아졸 유도체를 함유하는 항아로마타제제 | |
KR900700104A (ko) | 항불안제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |